Germain, D.P.; Porto Vasconcelos, A.; Tran Thi Phuong, L.; Bedreddine, N.; Turcan, M.; Trang, W.; Barache, L.
Safety and Tolerability of a Shorter Agalsidase Beta Infusion Time in Patients with Classic or Later-Onset Fabry Disease. Biomedicines 2024, 12, 2578.
https://doi.org/10.3390/biomedicines12112578
AMA Style
Germain DP, Porto Vasconcelos A, Tran Thi Phuong L, Bedreddine N, Turcan M, Trang W, Barache L.
Safety and Tolerability of a Shorter Agalsidase Beta Infusion Time in Patients with Classic or Later-Onset Fabry Disease. Biomedicines. 2024; 12(11):2578.
https://doi.org/10.3390/biomedicines12112578
Chicago/Turabian Style
Germain, Dominique P., Alice Porto Vasconcelos, Lien Tran Thi Phuong, Najya Bedreddine, Mihaela Turcan, Wenting Trang, and Lynda Barache.
2024. "Safety and Tolerability of a Shorter Agalsidase Beta Infusion Time in Patients with Classic or Later-Onset Fabry Disease" Biomedicines 12, no. 11: 2578.
https://doi.org/10.3390/biomedicines12112578
APA Style
Germain, D. P., Porto Vasconcelos, A., Tran Thi Phuong, L., Bedreddine, N., Turcan, M., Trang, W., & Barache, L.
(2024). Safety and Tolerability of a Shorter Agalsidase Beta Infusion Time in Patients with Classic or Later-Onset Fabry Disease. Biomedicines, 12(11), 2578.
https://doi.org/10.3390/biomedicines12112578
